Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-4-21
pubmed:abstractText
The aim of this study was to evaluate the diagnostic and prognostic utility of the type 1 growth factor receptor family in the management of differentiated thyroid cancer (DTC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1879-1883
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
195
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
667-73; discussion 673
pubmed:dateRevised
2011-11-2
pubmed:meshHeading
pubmed-meshheading:18424286-Adolescent, pubmed-meshheading:18424286-Adult, pubmed-meshheading:18424286-Aged, pubmed-meshheading:18424286-Aged, 80 and over, pubmed-meshheading:18424286-Female, pubmed-meshheading:18424286-Humans, pubmed-meshheading:18424286-Immunohistochemistry, pubmed-meshheading:18424286-Lymphatic Metastasis, pubmed-meshheading:18424286-Male, pubmed-meshheading:18424286-Middle Aged, pubmed-meshheading:18424286-Prognosis, pubmed-meshheading:18424286-Protein Array Analysis, pubmed-meshheading:18424286-Receptor, Epidermal Growth Factor, pubmed-meshheading:18424286-Receptor, erbB-2, pubmed-meshheading:18424286-Receptor, erbB-3, pubmed-meshheading:18424286-Risk Assessment, pubmed-meshheading:18424286-Sensitivity and Specificity, pubmed-meshheading:18424286-Thyroid Neoplasms, pubmed-meshheading:18424286-Thyroidectomy, pubmed-meshheading:18424286-Tumor Markers, Biological
pubmed:year
2008
pubmed:articleTitle
Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions.
pubmed:affiliation
Department of Surgery, St. Paul's Hospital, University of British Columbia, C303-1081 Burrard St., Vancouver, British Columbia, Canada V6Z-1Y6. smwiseman@providencehealth.bc.ca
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't